MedPath

ODM-207

Generic Name
ODM-207

ODM-207 in Patients With Advance Solid Tumours

Phase 1
Completed
Conditions
Solid Tumors
Interventions
First Posted Date
2017-01-30
Last Posted Date
2019-10-15
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
36
Registration Number
NCT03035591
Locations
🇫🇮

Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath